Didier Collard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Didier Collard has a total of 238 co-authors. Here are the top co-authors by number of shared publications:
- Bert Jan H van Den Born
Department of Public and Occupational Health, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands
17 shared publications - Liffert Vogt
Department of Internal Medicine, Section Nephrology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
9 shared publications - Henrike Galenkamp
Department of Public and Occupational Health, Amsterdam UMC, University of Amsterdam, the Netherlands
5 shared publications Bert-Jan H. van Den Born
Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam
4 shared publications- Lennart van de Velde
Multi-Modality Medical Imaging Group, TechMed Centre, University of Twente, Hallenweg 5, 7522 NH, Enschede, The Netherlands
4 shared publications - Max Nieuwdorp
Amsterdam UMC
4 shared publications
Latest Publications
- Open Access
Validation of individualized flow simulations for determining the pressure gradient in patients with renal artery stenosis
Objectives: To validate two computational fluid dynamics (CFD) models derived from computed tomography angiography (CTA) for estimating trans-stenotic pressure gradients, using invasive intra-arterial pressure measurements as the reference standard in patients with renal artery stenosis (RAS). Background: We assessed whether non-invasive assessment of the pressure gradient using CFD could be a reliable alternative to intra-arterial measurements for identifying hemodynamically significant RAS. Methods: We performed intra-arterial measurements at rest and during dopamine-induced hyperemia to assess the trans-stenotic pressure gradient in 28 patients with RAS. A pre-intervention CTA scan was used to simulate the pressure gradient with a CFD model using a strategy based on Murray’s law (CFD-Mu) and cortical volume (CFD-C). The agreement between the simulated and measured pressure gradients was assessed using intraclass correlation coefficients (ICC), Bland-Altman analysis and diagnostic agreement on the presence of a hemodynamically significant stenosis. Results: In 20 patients, successful measurements and simulations were obtained. The ICC between measured pressure gradient and the CFD pressure gradient was 0.78 and 0.94 during baseline and 0.86 and 0.72 during hyperemia, for CFD-Mu and CFD-C, respectively. The sensitivity of CFD-Mu and CFD-C was 70% for both models at rest and 100% compared to the hyperemic measurements, whereas the specificity was 90% and 70% at rest and 79% and 72% during hyperemia, respectively. Conclusions: The results support the use of individualized CFD simulations for hemodynamic assessment of RAS using CTA as input. The CFD models demonstrated high accuracy for the identification of a hemodynamically significant stenosis.
Open AccessValidation of individualized flow simulations for determining the pressure gradient in patients with renal artery stenosis
Objectives: To validate two computational fluid dynamics (CFD) models derived from computed tomography angiography (CTA) for estimating trans-stenotic pressure gradients, using invasive intra-arterial pressure measurements as the reference standard in patients with renal artery stenosis (RAS). Background: We assessed whether non-invasive assessment of the pressure gradient using CFD could be a reliable alternative to intra-arterial measurements for identifying hemodynamically significant RAS. Methods: We performed intra-arterial measurements at rest and during dopamine-induced hyperemia to assess the trans-stenotic pressure gradient in 28 patients with RAS. A pre-intervention CTA scan was used to simulate the pressure gradient with a CFD model using a strategy based on Murray’s law (CFD-Mu) and cortical volume (CFD-C). The agreement between the simulated and measured pressure gradients was assessed using intraclass correlation coefficients (ICC), Bland-Altman analysis and diagnostic agreement on the presence of a hemodynamically significant stenosis. Results: In 20 patients, successful measurements and simulations were obtained. The ICC between measured pressure gradient and the CFD pressure gradient was 0.78 and 0.94 during baseline and 0.86 and 0.72 during hyperemia, for CFD-Mu and CFD-C, respectively. The sensitivity of CFD-Mu and CFD-C was 70% for both models at rest and 100% compared to the hyperemic measurements, whereas the specificity was 90% and 70% at rest and 79% and 72% during hyperemia, respectively. Conclusions: The results support the use of individualized CFD simulations for hemodynamic assessment of RAS using CTA as input. The CFD models demonstrated high accuracy for the identification of a hemodynamically significant stenosis.
- Open Access
Improving the diagnostic performance of troponin assays for acute myocardial infarction in renal impairment
Background: Serum troponin measurement forms a cornerstone of acute myocardial infarction (AMI) diagnosis. A major challenge is interpretation of an elevated first troponin in patients with impaired renal function. We aimed to (1) evaluate the relationship between estimated glomerular filtration rate (eGFR) and first troponin, (2) characterise the performance of different troponin assays for diagnosing AMI and (3) derive eGFR-specific thresholds for potential clinical use. Methods: We analysed the distribution of troponin values stratified by eGFR and AMI. Diagnostic performance was analysed using the C-statistic. Test detection rate, false positive rate and positive predictive value were calculated for different cut-offs. Results: We included 221 175 patients between 2010 and 2017 from four acute tertiary care hospitals in London, UK, with a median age of 65 years (IQR 49–79). eGFR was90 (C-statistic 0.93) and worst in eGFR2 . Restricting the false positive rate to 15% yields eGFR specific cut-offs of 73, 112 and 184 ng/L, with detection rates of 73%, 70% and 68% in patients with an eGFR of 45–60, 30–45 or 15–30 mL/min/1.73 m 2 . Conclusions: The diagnostic performance of an unadjusted troponin cut-off for AMI falls with worsening renal function. We propose consideration of eGFR specific cut-offs to support more effective triage and early management of suspected AMI in patients with renal impairment. Trial registration number: NCT03507309 .
Open AccessImproving the diagnostic performance of troponin assays for acute myocardial infarction in renal impairment
Background: Serum troponin measurement forms a cornerstone of acute myocardial infarction (AMI) diagnosis. A major challenge is interpretation of an elevated first troponin in patients with impaired renal function. We aimed to (1) evaluate the relationship between estimated glomerular filtration rate (eGFR) and first troponin, (2) characterise the performance of different troponin assays for diagnosing AMI and (3) derive eGFR-specific thresholds for potential clinical use. Methods: We analysed the distribution of troponin values stratified by eGFR and AMI. Diagnostic performance was analysed using the C-statistic. Test detection rate, false positive rate and positive predictive value were calculated for different cut-offs. Results: We included 221 175 patients between 2010 and 2017 from four acute tertiary care hospitals in London, UK, with a median age of 65 years (IQR 49–79). eGFR was90 (C-statistic 0.93) and worst in eGFR2 . Restricting the false positive rate to 15% yields eGFR specific cut-offs of 73, 112 and 184 ng/L, with detection rates of 73%, 70% and 68% in patients with an eGFR of 45–60, 30–45 or 15–30 mL/min/1.73 m 2 . Conclusions: The diagnostic performance of an unadjusted troponin cut-off for AMI falls with worsening renal function. We propose consideration of eGFR specific cut-offs to support more effective triage and early management of suspected AMI in patients with renal impairment. Trial registration number: NCT03507309 .
- Open Access
- 30 April 2026
- Published by BMJ in BMJ Public Health
- Vol. 4 (2) , e003837
Trends in obesity prevalence and changes in adiposity across ethnic groups: findings from a population-based prospective cohort study in Amsterdam, the Netherlands (HELIUS study)
Background and aim: Obesity has reached epidemic proportions worldwide, with large differences across regions. European data on obesity trends among ethnic groups is scarce, particularly regarding the influence of age and socioeconomic status on these trends, which is crucial for guiding targeted interventions. In this study, we assessed the prevalence of obesity and changes in body mass index (BMI) and waist circumference (WC) over time and the effects of key sociodemographic factors on these changes using longitudinal data from a large multi-ethnic cohort. Methods: Using baseline and follow-up data from 10 484 participants in the HEalthy Life in an Urban Setting (HELIUS) study, representing Dutch, South-Asian Surinamese, African Surinamese, Ghanaian, Moroccan and Turkish populations; age-adjusted obesity prevalence; BMI and WC changes over an average follow-up of 6.3 (SD 1.2) years were calculated. Linear mixed models were used to assess changes in BMI and WC over time, adjusting for age, sex and socio-economic position. Key analyses were stratified by age (younger <50 years, older ≥50 years). Results: Median age of the baseline population was 48.0 years (IQR 38.0, 56.0), with 56.7% being women. Age-adjusted prevalence of obesity increased from 23.6% at baseline to 28.7% at follow-up, with steeper increases in ethnic minority groups compared with the Dutch origin group. The steepest increase in BMI and WC was observed in younger migrants, especially in those of Ghanaian and African-Surinamese descent. In older participants, only individuals of Ghanaian and Turkish descent showed a further increase in BMI over time. Conclusion: Obesity is increasingly prevalent in ethnic minority groups under 50 years, potentially raising obesity-related health risks and underscoring the need for targeted interventions to prevent further complications.
- 30 April 2026
- Published by BMJ in BMJ Public Health
- Vol. 4 (2) , e003837
Open AccessTrends in obesity prevalence and changes in adiposity across ethnic groups: findings from a population-based prospective cohort study in Amsterdam, the Netherlands (HELIUS study)
Background and aim: Obesity has reached epidemic proportions worldwide, with large differences across regions. European data on obesity trends among ethnic groups is scarce, particularly regarding the influence of age and socioeconomic status on these trends, which is crucial for guiding targeted interventions. In this study, we assessed the prevalence of obesity and changes in body mass index (BMI) and waist circumference (WC) over time and the effects of key sociodemographic factors on these changes using longitudinal data from a large multi-ethnic cohort. Methods: Using baseline and follow-up data from 10 484 participants in the HEalthy Life in an Urban Setting (HELIUS) study, representing Dutch, South-Asian Surinamese, African Surinamese, Ghanaian, Moroccan and Turkish populations; age-adjusted obesity prevalence; BMI and WC changes over an average follow-up of 6.3 (SD 1.2) years were calculated. Linear mixed models were used to assess changes in BMI and WC over time, adjusting for age, sex and socio-economic position. Key analyses were stratified by age (younger <50 years, older ≥50 years). Results: Median age of the baseline population was 48.0 years (IQR 38.0, 56.0), with 56.7% being women. Age-adjusted prevalence of obesity increased from 23.6% at baseline to 28.7% at follow-up, with steeper increases in ethnic minority groups compared with the Dutch origin group. The steepest increase in BMI and WC was observed in younger migrants, especially in those of Ghanaian and African-Surinamese descent. In older participants, only individuals of Ghanaian and Turkish descent showed a further increase in BMI over time. Conclusion: Obesity is increasingly prevalent in ethnic minority groups under 50 years, potentially raising obesity-related health risks and underscoring the need for targeted interventions to prevent further complications.
- Open Access
- 16 January 2025
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (7) , 1116-1124
Autonomic cardiac control independently predicts incident hypertension and systolic blood pressure in a multi-ethnic population: the HELIUS study
Aims: Cross-correlation baroreflex sensitivity (xBRS) and heart rate variability (HRV) are measures of autonomic cardiac control and are associated with hypertension. However, their value in predicting new-onset hypertension and changes in systolic blood pressure (SBP) remains elusive. Methods and results: We used longitudinal data of participants with and without a history of cardiovascular disease from the HEalthy Life In an Urban Setting (HELIUS) study. A non-invasive continuous finger blood pressure measurement at baseline was used to calculate xBRS and HRV. In normotensives at baseline, we calculated the odds ratio (OR) of developing hypertension at follow-up. In the full cohort, we assessed the change in SBP between baseline and follow-up using linear regression. Subgroup analyses were performed in the younger (<50 years) and older (≥50 years) participants. Median follow-up was 6.6 years (interquartile range 5.8–7.4). A 50% lower xBRS at baseline was independently associated with a 1.31 higher OR [95% confidence interval (CI) 1.09–1.57] of developing hypertension at follow-up. No significant associations between the standard deviation of the normal-to-normal interval (SDNN) or the square root of the mean of successive differences between adjacent normal-to-normal intervals (RMSSD), and new-onset hypertension were found. Compared to the lowest tertile, an xBRS in the highest tertile was associated with a 3.61 mmHg (95% CI 2.50–4.71) higher increase in SBP over time, whereas this was 1.11 mmHg (95% CI 0.12–2.09) and 1.76 mmHg (95% CI 0.73–2.79) for SDNN and RMSSD. Conclusion: In the general population, a lower xBRS is associated with increased odds of developing hypertension, and a steeper increase in SBP over time.
- 16 January 2025
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (7) , 1116-1124
Open AccessAutonomic cardiac control independently predicts incident hypertension and systolic blood pressure in a multi-ethnic population: the HELIUS study
Aims: Cross-correlation baroreflex sensitivity (xBRS) and heart rate variability (HRV) are measures of autonomic cardiac control and are associated with hypertension. However, their value in predicting new-onset hypertension and changes in systolic blood pressure (SBP) remains elusive. Methods and results: We used longitudinal data of participants with and without a history of cardiovascular disease from the HEalthy Life In an Urban Setting (HELIUS) study. A non-invasive continuous finger blood pressure measurement at baseline was used to calculate xBRS and HRV. In normotensives at baseline, we calculated the odds ratio (OR) of developing hypertension at follow-up. In the full cohort, we assessed the change in SBP between baseline and follow-up using linear regression. Subgroup analyses were performed in the younger (<50 years) and older (≥50 years) participants. Median follow-up was 6.6 years (interquartile range 5.8–7.4). A 50% lower xBRS at baseline was independently associated with a 1.31 higher OR [95% confidence interval (CI) 1.09–1.57] of developing hypertension at follow-up. No significant associations between the standard deviation of the normal-to-normal interval (SDNN) or the square root of the mean of successive differences between adjacent normal-to-normal intervals (RMSSD), and new-onset hypertension were found. Compared to the lowest tertile, an xBRS in the highest tertile was associated with a 3.61 mmHg (95% CI 2.50–4.71) higher increase in SBP over time, whereas this was 1.11 mmHg (95% CI 0.12–2.09) and 1.76 mmHg (95% CI 0.73–2.79) for SDNN and RMSSD. Conclusion: In the general population, a lower xBRS is associated with increased odds of developing hypertension, and a steeper increase in SBP over time.
- Open Access
Mid-life association between cardiovascular risk factors and cerebral blood flow in a multi-ethnic population
Background Cardiovascular (CV) risk factors are associated with cerebrovascular damage and cognitive decline in late life. However, it is unknown how different ethnic CV risk profiles are related to cerebral haemodynamics in mid-life. We aimed to investigate associations of CV risk factors with cerebral haemodynamics at two timepoints and examine the impact of ethnicity on these measures. Methods From the HELIUS study (53.0 years, 44.8% female), participants of Dutch (n=236), Moroccan (n=122), or South-Asian Surinamese (n=173) descent were included. Cerebral blood flow (CBF) and its spatial coefficient of variation (sCoV, marker of macrovascular efficiency) were obtained in both grey (GM) and white matter (WM). Associations of CV risk factors, WM hyperintensities (WMH), and carotid plaques with cerebral haemodynamics were investigated using linear regressions. Results CBF and sCoV differed per ethnicity. Only at the second visit associations were found, without an interaction with ethnicity; history of CV disease with lower GM CBF and higher WM sCoV, higher total cholesterol and lower WMH volume with lower WM CBF, smoking with higher WM sCoV, and higher SBP with lower GM sCoV. Conclusions These findings emphasise the need to further explore the longitudinal effects of midlife risk factors and cerebrovascular health, and its interaction with ethnicity.
Open AccessMid-life association between cardiovascular risk factors and cerebral blood flow in a multi-ethnic population
Background Cardiovascular (CV) risk factors are associated with cerebrovascular damage and cognitive decline in late life. However, it is unknown how different ethnic CV risk profiles are related to cerebral haemodynamics in mid-life. We aimed to investigate associations of CV risk factors with cerebral haemodynamics at two timepoints and examine the impact of ethnicity on these measures. Methods From the HELIUS study (53.0 years, 44.8% female), participants of Dutch (n=236), Moroccan (n=122), or South-Asian Surinamese (n=173) descent were included. Cerebral blood flow (CBF) and its spatial coefficient of variation (sCoV, marker of macrovascular efficiency) were obtained in both grey (GM) and white matter (WM). Associations of CV risk factors, WM hyperintensities (WMH), and carotid plaques with cerebral haemodynamics were investigated using linear regressions. Results CBF and sCoV differed per ethnicity. Only at the second visit associations were found, without an interaction with ethnicity; history of CV disease with lower GM CBF and higher WM sCoV, higher total cholesterol and lower WMH volume with lower WM CBF, smoking with higher WM sCoV, and higher SBP with lower GM sCoV. Conclusions These findings emphasise the need to further explore the longitudinal effects of midlife risk factors and cerebrovascular health, and its interaction with ethnicity.
- Open Access
- 1 October 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (10) , 2124-2136
Effects of Oral Butyrate on Blood Pressure in Patients With Hypertension: A Randomized, Placebo-Controlled Trial
BACKGROUND: The microbiota-derived short chain fatty acid butyrate has been shown to lower blood pressure (BP) in rodent studies. Nonetheless, the net effect of butyrate on hypertension in humans remains uncovered. In this study, for the first time, we aimed to determine the effect of oral butyrate on BP in patients with hypertension. METHODS: We performed a double-blind randomized placebo-controlled trial including 23 patients with hypertension. Antihypertensive medication was discontinued for the duration of the study with a washout period of 4 weeks before starting the intervention. Participants received daily oral capsules containing either sodium butyrate or placebo with an equivalent dosage of sodium chloride for 4 weeks. The primary outcome was daytime 24-hour systolic BP. Differences between groups over time were assessed using linear mixed models (group-by-time interaction). RESULTS: Study participants (59.0±3.7 years; 56.5% female) had an average baseline office systolic BP of 143.5±14.6 mm Hg and diastolic BP of 93.0±8.3 mm Hg. Daytime 24-hour systolic and diastolic BP significantly increased over the intervention period in the butyrate compared with the placebo group, with an increase of +9.63 (95% CI, 2.02–17.20) mm Hg in daytime 24-hour systolic BP and +5.08 (95% CI, 1.34–8.78) mm Hg in diastolic BP over 4 weeks. Butyrate levels significantly increased in plasma, but not in feces, upon butyrate intake, underscoring its absorption. CONCLUSIONS: Four-week treatment with oral butyrate increased daytime systolic and diastolic BP in subjects with hypertension. Our findings implicate that butyrate does not have beneficial effects on human hypertension, which warrants caution in future butyrate intervention studies. REGISTRATION: URL: https://onderzoekmetmensen.nl/ ; Unique identifier: NL8924.
- 1 October 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (10) , 2124-2136
Open AccessEffects of Oral Butyrate on Blood Pressure in Patients With Hypertension: A Randomized, Placebo-Controlled Trial
BACKGROUND: The microbiota-derived short chain fatty acid butyrate has been shown to lower blood pressure (BP) in rodent studies. Nonetheless, the net effect of butyrate on hypertension in humans remains uncovered. In this study, for the first time, we aimed to determine the effect of oral butyrate on BP in patients with hypertension. METHODS: We performed a double-blind randomized placebo-controlled trial including 23 patients with hypertension. Antihypertensive medication was discontinued for the duration of the study with a washout period of 4 weeks before starting the intervention. Participants received daily oral capsules containing either sodium butyrate or placebo with an equivalent dosage of sodium chloride for 4 weeks. The primary outcome was daytime 24-hour systolic BP. Differences between groups over time were assessed using linear mixed models (group-by-time interaction). RESULTS: Study participants (59.0±3.7 years; 56.5% female) had an average baseline office systolic BP of 143.5±14.6 mm Hg and diastolic BP of 93.0±8.3 mm Hg. Daytime 24-hour systolic and diastolic BP significantly increased over the intervention period in the butyrate compared with the placebo group, with an increase of +9.63 (95% CI, 2.02–17.20) mm Hg in daytime 24-hour systolic BP and +5.08 (95% CI, 1.34–8.78) mm Hg in diastolic BP over 4 weeks. Butyrate levels significantly increased in plasma, but not in feces, upon butyrate intake, underscoring its absorption. CONCLUSIONS: Four-week treatment with oral butyrate increased daytime systolic and diastolic BP in subjects with hypertension. Our findings implicate that butyrate does not have beneficial effects on human hypertension, which warrants caution in future butyrate intervention studies. REGISTRATION: URL: https://onderzoekmetmensen.nl/ ; Unique identifier: NL8924.
- 16 January 2024
- Published by SAGE Publications in Thyroid®
- Vol. 34 (1) , 101-111
Comparative Analysis of Taxonomic and Functional Gut Microbiota Profiles in Relation to Seroconversion of Thyroid Peroxidase Antibodies in Euthyroid Participants
Background: Previous studies have reported gut microbiome alterations in Hashimoto's autoimmune thyroiditis (HT) patients. Yet, it is unknown whether an aberrant microbiome is present before clinical disease onset in participants susceptible to HT or whether it reflects the effects of the disease itself. In this study, we report for the first time a comprehensive characterization of the taxonomic and functional profiles of the gut microbiota in euthyroid seropositive and seronegative participants. Our primary goal was to determine taxonomic and functional signatures of the intestinal microbiota associated with serum thyroid peroxidase antibodies (TPOAb). A secondary aim was to determine whether different ethnicities warrant distinct reference intervals for accurate interpretation of serum thyroid biomarkers. Methods: In this cross-sectional study, euthyroid participants with ( N = 159) and without ( N = 1309) TPOAb were selected from the multiethnic (European Dutch, Moroccan, and Turkish) HEalthy Life In an Urban Setting (HELIUS) cohort. Fecal microbiota composition was profiled using 16S rRNA sequencing. Differences between the groups were analyzed based on the overall composition (alpha and beta diversity), as well as differential abundance (DA) of microbial taxa and functional pathways using multiple DA tools. Results: Overall composition showed a substantial overlap between the two groups ( p > 0.05 for alpha-diversity; p = 0.39 for beta-diversity), indicating that TPOAb-seropositivity does not significantly differentiate gut microbiota composition and diversity. Interestingly, TPOAb status accounted for only a minor fraction (0.07%) of microbiome variance ( p = 0.545). Further exploration of taxonomic differences identified 138 taxa nominally associated with TPOAb status. Among these, 13 taxa consistently demonstrated nominal significance across three additional DA methods, alongside notable associations within various functional pathways. Furthermore, we showed that ethnicity-specific reference intervals for serum thyroid biomarkers are not required, as no significant disparities in serum thyroid markers were found among the three ethnic groups residing in an iodine-replete area ( p > 0.05 for thyrotropin, free thyroxine, and TPOAb). Conclusion: These findings suggest that there is no robust difference in gut microbiome between individuals with or without TPOAb in terms of alpha and beta-diversity. Nonetheless, several taxa were identified with nominal significance related to TPOAb presence. Further research is required to determine whether these changes indeed imply a higher risk of overt HT.
- 16 January 2024
- Published by SAGE Publications in Thyroid®
- Vol. 34 (1) , 101-111
Comparative Analysis of Taxonomic and Functional Gut Microbiota Profiles in Relation to Seroconversion of Thyroid Peroxidase Antibodies in Euthyroid Participants
Background: Previous studies have reported gut microbiome alterations in Hashimoto's autoimmune thyroiditis (HT) patients. Yet, it is unknown whether an aberrant microbiome is present before clinical disease onset in participants susceptible to HT or whether it reflects the effects of the disease itself. In this study, we report for the first time a comprehensive characterization of the taxonomic and functional profiles of the gut microbiota in euthyroid seropositive and seronegative participants. Our primary goal was to determine taxonomic and functional signatures of the intestinal microbiota associated with serum thyroid peroxidase antibodies (TPOAb). A secondary aim was to determine whether different ethnicities warrant distinct reference intervals for accurate interpretation of serum thyroid biomarkers. Methods: In this cross-sectional study, euthyroid participants with ( N = 159) and without ( N = 1309) TPOAb were selected from the multiethnic (European Dutch, Moroccan, and Turkish) HEalthy Life In an Urban Setting (HELIUS) cohort. Fecal microbiota composition was profiled using 16S rRNA sequencing. Differences between the groups were analyzed based on the overall composition (alpha and beta diversity), as well as differential abundance (DA) of microbial taxa and functional pathways using multiple DA tools. Results: Overall composition showed a substantial overlap between the two groups ( p > 0.05 for alpha-diversity; p = 0.39 for beta-diversity), indicating that TPOAb-seropositivity does not significantly differentiate gut microbiota composition and diversity. Interestingly, TPOAb status accounted for only a minor fraction (0.07%) of microbiome variance ( p = 0.545). Further exploration of taxonomic differences identified 138 taxa nominally associated with TPOAb status. Among these, 13 taxa consistently demonstrated nominal significance across three additional DA methods, alongside notable associations within various functional pathways. Furthermore, we showed that ethnicity-specific reference intervals for serum thyroid biomarkers are not required, as no significant disparities in serum thyroid markers were found among the three ethnic groups residing in an iodine-replete area ( p > 0.05 for thyrotropin, free thyroxine, and TPOAb). Conclusion: These findings suggest that there is no robust difference in gut microbiome between individuals with or without TPOAb in terms of alpha and beta-diversity. Nonetheless, several taxa were identified with nominal significance related to TPOAb presence. Further research is required to determine whether these changes indeed imply a higher risk of overt HT.
- 1 December 2023
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 325 (6) , F707-F716
Salt-sensitive trait of normotensive individuals is associated with altered autonomous cardiac regulation: a randomized controlled intervention study
Extracellular fluid expansion in normotensive individuals after salt loading is present in both salt-sensitive and salt-resistant individuals and is not discriminatory to the blood pressure response to sodium loading in a steady-state measurement. In normotensive subjects, the ability to sufficiently vasodilate seems to play a pivotal role in salt sensitivity. In a normotensive cohort, differences in sympathovagal balance are also present in low-salt conditions rather than being affected by salt loading. Whereas treatment and prevention of salt-sensitive blood pressure increase are mostly focused on renal sodium handling and extracellular volume regulation, our study suggests that an inability to adequately vasodilate and altered autonomous cardiac functioning are additional key players in the pathophysiology of salt-sensitive blood pressure increase.
- 1 December 2023
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 325 (6) , F707-F716
Salt-sensitive trait of normotensive individuals is associated with altered autonomous cardiac regulation: a randomized controlled intervention study
Extracellular fluid expansion in normotensive individuals after salt loading is present in both salt-sensitive and salt-resistant individuals and is not discriminatory to the blood pressure response to sodium loading in a steady-state measurement. In normotensive subjects, the ability to sufficiently vasodilate seems to play a pivotal role in salt sensitivity. In a normotensive cohort, differences in sympathovagal balance are also present in low-salt conditions rather than being affected by salt loading. Whereas treatment and prevention of salt-sensitive blood pressure increase are mostly focused on renal sodium handling and extracellular volume regulation, our study suggests that an inability to adequately vasodilate and altered autonomous cardiac functioning are additional key players in the pathophysiology of salt-sensitive blood pressure increase.
- Open Access
- 21 November 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (22) , e031418
Association Between Self‐Rated Medication Adherence and Adverse Cardiovascular Outcomes in Patients With Hypertension
Background: Medication nonadherence contributes to poor health outcomes but remains challenging to identify. This study assessed the association between self‐rated adherence and systolic blood pressure, low‐density lipoprotein cholesterol levels, cardiovascular events, and all‐cause mortality in SPRINT (Systolic Blood Pressure Intervention Trial). Methods and Results: A total of 9361 patients randomized to 2 systolic blood pressure target groups, <120 mm Hg (intensive) and 80%, respectively. Linear mixed effect regression models and Cox proportional hazard models were used to evaluate the association between self‐rated adherence and systolic blood pressure and low‐density lipoprotein cholesterol and cardiovascular events and all‐cause mortality, respectively. A total of 9278 participants (mean age 68±9.4 years, 35.6% female) had repeated self‐rated adherence measurements available, with a mean of 15±4 measurements per participant over 3.8 years follow‐up. Of these, 2694 participants (29.0%) had ≥1 adherence measurements ≤80%. Compared with high‐adherent patients, patients with lower adherence had significantly higher estimated on‐treatment systolic blood pressure at 2‐year follow‐up: 128.7 (95% CI, 127.6–129.9) versus 120.0 (95% CI, 119.7–120.2) mm Hg in the intensive arm; and 139.8 (95% CI 138.4–141.1) versus 135.0 (95% CI 134.7–135.2) in the standard arm. Moreover, lower adherence was associated with an estimated 11 mg/dL higher low‐density lipoprotein cholesterol level, more cardiovascular events (hazard ratio [HR], 1.69 [95% CI, 1.20–2.39]), and higher all‐cause mortality (HR, 1.63 [95% CI, 1.16–2.31]). Conclusions: Self‐rated adherence allows identification of lower medication adherence and correlates with blood pressure control, low‐density lipoprotein cholesterol levels, and adverse outcomes.
- 21 November 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (22) , e031418
Open AccessAssociation Between Self‐Rated Medication Adherence and Adverse Cardiovascular Outcomes in Patients With Hypertension
Background: Medication nonadherence contributes to poor health outcomes but remains challenging to identify. This study assessed the association between self‐rated adherence and systolic blood pressure, low‐density lipoprotein cholesterol levels, cardiovascular events, and all‐cause mortality in SPRINT (Systolic Blood Pressure Intervention Trial). Methods and Results: A total of 9361 patients randomized to 2 systolic blood pressure target groups, <120 mm Hg (intensive) and 80%, respectively. Linear mixed effect regression models and Cox proportional hazard models were used to evaluate the association between self‐rated adherence and systolic blood pressure and low‐density lipoprotein cholesterol and cardiovascular events and all‐cause mortality, respectively. A total of 9278 participants (mean age 68±9.4 years, 35.6% female) had repeated self‐rated adherence measurements available, with a mean of 15±4 measurements per participant over 3.8 years follow‐up. Of these, 2694 participants (29.0%) had ≥1 adherence measurements ≤80%. Compared with high‐adherent patients, patients with lower adherence had significantly higher estimated on‐treatment systolic blood pressure at 2‐year follow‐up: 128.7 (95% CI, 127.6–129.9) versus 120.0 (95% CI, 119.7–120.2) mm Hg in the intensive arm; and 139.8 (95% CI 138.4–141.1) versus 135.0 (95% CI 134.7–135.2) in the standard arm. Moreover, lower adherence was associated with an estimated 11 mg/dL higher low‐density lipoprotein cholesterol level, more cardiovascular events (hazard ratio [HR], 1.69 [95% CI, 1.20–2.39]), and higher all‐cause mortality (HR, 1.63 [95% CI, 1.16–2.31]). Conclusions: Self‐rated adherence allows identification of lower medication adherence and correlates with blood pressure control, low‐density lipoprotein cholesterol levels, and adverse outcomes.